Table 1 Characteristics of the syphilis episodes (N = 288)
From: Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapy
Age, year | 41 (33–48) |
Male, n (%) | 287 (99.7) |
Nadir CD4 (cells/mm 3 ) | 197 (51–293) |
Plasma viral suppression (< 50 copies/ml) at T1, n (%) | 280 (97) |
Duration between T1 & T2, days | 168 (110–210) |
Duration between T2 & syphilis treatment, days | 16 (11–39) |
Duration between syphilis treatment & T3, days | 116 (84–175) |
Syphilis re-infection (positive syphilis EIA at T1), n (%) | 221 (77) |
Treatment regimen, n (%) Penicillin Doxycycline Ceftriaxone Unknown | 258 (90) 15 (5) 11 (4) 4 (1) |